Anaphylaktische reaktionen im kindesalter. Akuttherapie und risikoabschätzung

Translated title of the contribution: Anaphylaxis in children. Treating the acute episode and risk assessment

M. Kopp, Radvan Urbanek*

*Corresponding author for this work


Recent investigations have found increases in the prevalence of anaphylaxis. Among children the most identifiable cause of anaphylactic reactions is insect sting and food allergy. It is important to consider the risk factors as asthma history and previous respiratory or cardiovascular symptoms after exposure to trace amount of allergen, and finally to treat the anaphylactic reaction immediately. To help distinguished sensitized individuals of minimum or no risk from those at increased risk of developing anaphylaxis measurement of the allergen-specific and total IgE antibodies, mast cell and basophil activation markers and, in particular patients, challenge tests were introduced. Patients with a history of anaphylaxis need an individual management plan on how to recognize the anaphylactic symptoms as well as instructions how to use the emergency medication kit. Epinephrin should be administered preferably intramuscularly, self-injectors are available. The lasting therapeutic strategy for venom hypersensitivity is venom specific immunotherapy and in some cases of food allergy a specific oral tolerance induction.

Translated title of the contributionAnaphylaxis in children. Treating the acute episode and risk assessment
Original languageGerman
JournalInternistische Praxis
Issue number4
Pages (from-to)783-791
Number of pages9
Publication statusPublished - 12.2013

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Anaphylaxis in children. Treating the acute episode and risk assessment'. Together they form a unique fingerprint.

Cite this